|

Dapagliflozin (DAPA) Clinical Trials

2 actively recruiting trials

Also known as: Dapagliflozin

Pipeline

Phase 3: 1Phase 4: 1

Top Sponsors

  • Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1
  • Erbil Polytechnic University1

Indications

  • Diabetes2
  • Type 2 Diabetes2
  • Obese Patients (BMI ≥ 30 kg/m²)1
  • Obese Diabetics1

Other2 trials

A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
Phase 3
The Role of CYP8B1 Polymorphisms in Modulating the Biochemical Pathways Affected by SGLT2 Inhibitors in T2DM and Obesity
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.